September 15, 2021
Rare Disease Innovation and Data Sharing Accelerated by New RDCA-DAP Program
Related Posts
-
C-Path’s European Nonprofit Appoints Managing Director and New Board Member to Expand Global Efforts -
Rare Disease Workshop Highlights the Importance of Data Sharing in Drug Development -
C-Path Awarded FDA Grant to Establish Public-Private Partnership to Advance Treatments for Rare Neurodegenerative Diseases -
C-Path’s Kristen Swingle Named President
-
C-Path to Lead Pre-Consortium Aimed at Transforming, Accelerating Medical Product Development in Lysosomal Diseases